Skip to main content

Table 1 Baseline characteristics of study patients according to nutritional status

From: Prognostic impact of malnutrition on cardiovascular events in coronary artery disease patients with myocardial damage

Variables

Overall

Malnourished group

Non-malnourished group

p value

(n = 241)

(n = 55)

(n = 186)

Age, years

70 ± 11

77 ± 9

67 ± 11

 < 0.001

Sex, male, n (%)

163 (68)

29 (53)

134 (72)

0.009

BMI, kg/m2

23.1 [21.2, 25.5]

20.1 [18.5, 21.5]

24.5 [22.3, 26.4]

 < 0.001

Risk factors, n (%)

 Hypertension

191 (79)

44 (80)

147 (79)

1.00

 Diabetes mellitus

149 (61)

38 (69)

111 (60)

0.27

 Dyslipidemia

164 (68)

26 (47)

138 (74)

 < 0.001

 Current smoking

45 (19)

7 (13)

38 (20)

0.24

 Hemodialysis

66 (27)

23 (42)

43 (23)

0.009

 Prior myocardial infarction

21 (9)

8 (15)

13 (7)

0.101

 Prior stroke

15 (6)

2 (4)

13 (7)

0.53

 Prior heart failure

20 (8)

7 (13)

13 (7)

0.18

Medication, n (%)

 Calcium-channel blocker

120 (50)

27 (49)

93 (50)

1.00

 ACEI

19 (8)

4 (7)

15 (8)

1.00

 ARB

79 (33)

14 (25)

65 (35)

0.25

 β-blocker

48 (20)

10 (18)

38 (20)

0.85

 Statin

112 (46)

18 (33)

94 (51)

0.022

 Proton pump inhibitor

50 (21)

12 (22)

38 (20)

0.85

Laboratory data

 Cholinesterase, U/L

268 [208, 335]

194 [148, 253]

284 [236, 351]

 < 0.001

 hs-CRP, mg/dL

0.26 [0.09, 1.23]

3.1 [0.36, 8.26]

0.19 [0.08, 0.58]

 < 0.001

 T-CHO, mg/dL

164 [140, 197]

155 [131, 171]

172 [142, 203]

0.002

 LDL-C, mg/dL

90 [71, 117]

86 [71, 112]

92 [71, 120]

0.22

 HDL-C, mg/dL

46 [39, 58]

43 [35, 58]

46 [40, 57]

0.121

 Triglyceride, mg/dL

107 [78, 155]

89 [64, 127]

114 [86, 159]

 < 0.001

 Albumin, g/dL

3.9 [3.4, 4.2]

3.0 [2.7, 3.4]

4.0 [3.7, 4.3]

 < 0.001

 Uric acid, mg/dL

5.5 [4.2, 6.7]

5.6 [3.8, 6.7]

5.4 [4.3, 6.7]

0.61

 FPG, mg/dL

121 [98,153]

120 [99, 163]

121 [98, 151]

0.99

 eGFR, mL/min/1.73 m2

47.9 [11.3, 65.6]

19.2 [9.5, 54.7]

51.4 [20.0, 70.7]

0.004

LVEF, %

55.0 [41.4, 66.2]

49.4 [38.8, 64.9]

56.8 [45.8, 67.2]

0.030

  1. Values are shown as mean ± standard deviation or median with interquartile range
  2. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, BMI body mass index, eGFR estimated glomerular filtration rate, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, LVEF left ventricular ejection fraction, LDL-C low-density lipoprotein cholesterol, T-CHO total cholesterol
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us